Photodynamic therapy for AMD and non-AMD patients: one-year results in Thais.
dc.contributor.author | Ratanasukon, Mansing | en_US |
dc.contributor.author | Visaetsilpanonta, Siriraksa | en_US |
dc.contributor.author | Hanutsaha, Prut | en_US |
dc.contributor.author | Patikulsila, Direk | en_US |
dc.date.accessioned | 2009-05-27T19:27:24Z | |
dc.date.available | 2009-05-27T19:27:24Z | |
dc.date.issued | 2007-10-29 | en_US |
dc.description | Chotmaihet Thangphaet. | en_US |
dc.description.abstract | OBJECTIVE: To evaluate the effect of photodynamic therapy (PDT) with verteporfin for age-related macular degeneration (AMD) and non-AMD in Thais, and compare with the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) study. MATERIAL AND METHOD: The authors prospectively evaluated all data of 51 eyes of 51 patients who had undergone PDT and accomplished a 1-year follow up. The assessments were divided into two categories: group 1 included three subsets of AMD, and group 2 was non-AMD. The first group classified into three subgroups: group 1A: AMD with subfoveal choroidal neovascularization (CNV) and TAP/VIP compatible with recommendation guidelines characteristics, group 1B: AMD with subfoveal CNV and TAP/VIP incompatible, and group 1C: AMD with non-subfoveal CNV. The measurement outcomes comprised of the baseline characteristics, change in visual acuity, and number of treatments. RESULTS: Thirty-eight eyes had CNV-related AMD and 13 eyes were non-AMD. At the 12-month examination, the mean visual acuity change in group 1A, 1B, 1C had increased 0.19 (p = 0.077), 0.14 (p = 0.076), and 0.24 (p = 0.003), respectively. The number of treatments was 1.8 in group 1A, 2.3 in group 1B, and 1.5 in group 1C. CONCLUSION: PDT is beneficial to Thai patients with AMD at first year even if they were not compatible with TAP/VIP criteria. | en_US |
dc.description.affiliation | Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. mratanasukon@yahoo.com | en_US |
dc.identifier.citation | Ratanasukon M, Visaetsilpanonta S, Hanutsaha P, Patikulsila D. Photodynamic therapy for AMD and non-AMD patients: one-year results in Thais. Journal of the Medical Association of Thailand. 2007 Oct; 90(10): 2090-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/41162 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.mat.or.th/journal/all.php | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Choroidal Neovascularization | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Macular Degeneration --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Photochemotherapy | en_US |
dc.subject.mesh | Porphyrins --administration & dosage | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Thailand | en_US |
dc.subject.mesh | Time Factors | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.subject.mesh | Visual Acuity | en_US |
dc.title | Photodynamic therapy for AMD and non-AMD patients: one-year results in Thais. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1